|Articles|January 2, 2004
- Pharmaceutical Technology-01-02-2004
- Volume 28
- Issue 1
Medicare Bill Contains Significant Changes for Drug Manufacturers
Author(s)Jill Wechsler
The new Medicare bill affects pricing and coverage, revises payment formula, and clarifies generic patent issues.
Advertisement
Articles in this issue
almost 22 years ago
Coprocessed Excipients for Solid Dosage Formsalmost 22 years ago
Manufacturing Execution Systemsalmost 22 years ago
State-of-the-Art Packaging Machinesalmost 22 years ago
January 2004almost 22 years ago
The Bioterrorism Actalmost 22 years ago
New Supply-Chain Dynamicsalmost 22 years ago
In the Spotlight--February 2004almost 22 years ago
January 2004Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
US and European Pharma Manufacturing Face Diverging Paths to Resilience
4
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
5
